ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,830, issued on June 17, was assigned to Ariceum Therapeutics GmbH (Berlin).

"Composition containing a somatostatin analogue for radiopharmaceutical use" was invented by Romain Bejot (Wrexham, Great Britain), Bilal Karaaoui (Dreux, France), Didier Kubiak (Dreux, France), Anne-Claire Le Meur (Dreux, France), Didier Nourrisson (Dreux, France), Anne Petit (Dreux, France), Joel Richard (Dreux, France) and Camille Toulisse (Dreux, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somat...